Literature DB >> 17050609

Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus.

Melanie M Brinkmann1, Marcel Pietrek, Oliver Dittrich-Breiholz, Michael Kracht, Thomas F Schulz.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) contains several open reading frames (ORFs) encoding proteins capable of initiating signal transduction pathways. Among them is the K15 ORF, which consists of eight exons encoding a protein with 12 predicted transmembrane domains and a cytoplasmic C terminus. When transiently expressed, the 8-exon K15 transcript gives rise to a protein with an apparent molecular mass of 45 kDa. K15 interacts with cellular proteins, TRAF (tumor necrosis factor receptor-associated factor) and Src kinases, and activates AP-1, NF-kappaB, and the mitogen-activated protein kinases (MAPKs) c-jun-N-terminal kinase and extracellular signal-regulated kinase. This signaling activity of K15 is related to phosphorylation of Y(481) of the K15 SH2-B motif Y(481)EEV. In this study we demonstrate the expression of an endogenous 45-kDa K15 protein in KSHV BAC36-infected epithelial cells. This endogenous K15 protein shows the same intracellular localization as transiently expressed K15, and expression kinetic studies suggest it to be a lytic gene. We have further determined the downstream target genes of K15 signaling using DNA oligonucleotide microarrays. We demonstrate that K15 is capable of inducing expression of multiple cytokines and chemokines, including interleukin-8 (IL-8), IL-6, CCL20, CCL2, CXCL3, and IL-1alpha/beta, as well as expression of Dscr1 and Cox-2. In epithelial cells, K15-induced upregulation of most genes was dependent on phosphorylation of Y(481), whereas in endothelial cells mutation of Y(481) did not result in a complete loss of Dscr1 and Cox-2 expression and NFAT-activity. Our study establishes K15 as one of the KSHV lytic genes that are inducing expression of multiple cytokines, which have been shown to play an important role in KSHV-associated pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050609      PMCID: PMC1797256          DOI: 10.1128/JVI.00648-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  137 in total

1.  Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74.

Authors:  M M Rosenkilde; T N Kledal; H Bräuner-Osborne; T W Schwartz
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

2.  EBV induces the production and release of IL-8 and macrophage inflammatory protein-1 alpha in human neutrophils.

Authors:  S R McColl; C J Roberge; B Larochelle; J Gosselin
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

3.  Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins.

Authors:  S H Gee; R Madhavan; S R Levinson; J H Caldwell; R Sealock; S C Froehner
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

4.  Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration.

Authors:  J E Grundy; K M Lawson; L P MacCormac; J M Fletcher; K L Yong
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

5.  Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system.

Authors:  J A Reed; R G Nador; D Spaulding; Y Tani; E Cesarman; D M Knowles
Journal:  Blood       Date:  1998-05-15       Impact factor: 22.113

6.  Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells.

Authors:  R Renne; D Blackbourn; D Whitby; J Levy; D Ganem
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

7.  Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice.

Authors:  C Boshoff; S J Gao; L E Healy; S Matthews; A J Thomas; L Coignet; R A Warnke; J A Strauchen; E Matutes; O W Kamel; P S Moore; R A Weiss; Y Chang
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

8.  Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells.

Authors:  H Asou; J W Said; R Yang; R Munker; D J Park; N Kamada; H P Koeffler
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

9.  Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma.

Authors:  J Vieira; M L Huang; D M Koelle; L Corey
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

10.  G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.

Authors:  C Bais; B Santomasso; O Coso; L Arvanitakis; E G Raaka; J S Gutkind; A S Asch; E Cesarman; M C Gershengorn; E A Mesri; M C Gerhengorn
Journal:  Nature       Date:  1998-01-01       Impact factor: 49.962

View more
  48 in total

1.  Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation.

Authors:  Marcel Pietrek; Melanie M Brinkmann; Ilona Glowacka; Anette Enlund; Anika Hävemeier; Oliver Dittrich-Breiholz; Michael Kracht; Marc Lewitzky; Kalle Saksela; Stephan M Feller; Thomas F Schulz
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 2.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

3.  A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Thomas J Ellison; Yoshihiro Izumiya; Chie Izumiya; Paul A Luciw; Hsing-Jien Kung
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

Review 4.  Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Authors:  Emily Cousins; John Nicholas
Journal:  Recent Results Cancer Res       Date:  2014

5.  Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.

Authors:  Bizunesh Abere; Naira Samarina; Silvia Gramolelli; Jessica Rückert; Gisa Gerold; Andreas Pich; Thomas F Schulz
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

6.  K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus.

Authors:  Lisa Steinbrück; Montse Gustems; Stephanie Medele; Thomas F Schulz; Dominik Lutter; Wolfgang Hammerschmidt
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

7.  Activation of NF-κB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-κB-inducing kinase, IκB kinases, and phosphorylation of p65.

Authors:  Anika Hävemeier; Silvia Gramolelli; Marcel Pietrek; Ramona Jochmann; Michael Stürzl; Thomas F Schulz
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

8.  Induction of angiogenic chemokine CCL2 by human herpesvirus 8 chemokine receptor.

Authors:  Young Bong Choi; John Nicholas
Journal:  Virology       Date:  2009-12-09       Impact factor: 3.616

Review 9.  Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.

Authors:  Fang Wei; Qing Zhu; Ling Ding; Qing Liang; Qiliang Cai
Journal:  Virol Sin       Date:  2016-09-12       Impact factor: 4.327

10.  Multi-transmembrane protein K15 of Kaposi's sarcoma-associated herpesvirus targets Lyn kinase in the membrane raft and induces NFAT/AP1 activities.

Authors:  Nam-Hyuk Cho; Young-Ki Choi; Joong-Kook Choi
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.